Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on April 20, 2012, primarily to announce its financial results for the first quarter ended March 31, 2012. The report itself does not contain the detailed financial figures but rather references a press release (Exhibit 99.1) which was issued concurrently with the filing. Investors should refer to this press release for specific data on revenue, earnings, and other key financial metrics for the first quarter of 2012. The filing also confirms the Chief Financial Officer, Merilee Raines, as the signatory.
Key Highlights
- 1IDEXX Laboratories announced its first-quarter 2012 financial results on April 20, 2012.
- 2The detailed financial results are contained within a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3The filing is made under Item 2.02 (Results of Operations and Financial Condition) of Form 8-K.
- 4Information furnished under Item 2.02 is not considered 'filed' for certain liability purposes under the Securities Exchange Act of 1934, unless expressly incorporated into other filings.
- 5The press release provides the company's performance data for the quarter ending March 31, 2012.
- 6Merilee Raines, Corporate Vice President, Chief Financial Officer and Treasurer, signed the report on behalf of IDEXX Laboratories.